Characterisation of chromatin modifiers in endometrial cancer

Characterisation of chromatin modifiers in endometrial cancer

<p>Chromatin organization is a critical regulator of gene expression and cell phenotype, and is frequently dysregulated in cancer. Endometrial cancer (EC) is the most common gynecological malignancy, and casues significant morbidity and mortality. EC is notable for recurrent alterations in chr...

Descripció completa

Dades bibliogràfiques
Autor principal:	Kedzierska, KZ
Altres autors:	Church, D
Format:	Thesis
Idioma:	English
Publicat:	2024
Matèries:	Cancer

Ítems similars

Characterisation of Levonorgestrel-Resistant Endometrial Cancer Cells
per: Dore M, et al.
Publicat: (2021-10-01)

Prognostic Significance of Dysregulated Epigenomic and Chromatin Modifiers in Cervical Cancer
per: Aswathy Mary Paul, et al.
Publicat: (2021-10-01)

A novel chromatin regulator-related immune checkpoint related gene prognostic signature and potential candidate drugs for endometrial cancer patients
per: Zesi Liu, et al.
Publicat: (2022-10-01)

Characterising ISWI chromatin remodeler in Trypanosoma cruzi
per: Yirys Díaz-Olmos, et al.

Druggable genetic targets in endometrial cancer✰,✰✰
per: Steven Lehrer, et al.
Publicat: (2022-01-01)

The treatment of special types of endometrial cancer
per: Meng Zhang, et al.
Publicat: (2022-08-01)

Endometrial Atypical Hyperplasia and Risk of Endometrial Cancer
per: An-Ju Chou, et al.
Publicat: (2024-11-01)

Genomic profiling of endometrial cancer and relationship with volume of endometrial cancer disease spread
per: Stephanie A. Sullivan, et al.
Publicat: (2021-05-01)

Importance of the endometrial immune environment in endometrial cancer and associated therapies
per: Hannah van der Woude, et al.
Publicat: (2022-08-01)

How Immunotherapy Modified the Therapeutic Scenario of Endometrial Cancer: A Systematic Review
per: Brigida Anna Maiorano, et al.
Publicat: (2022-04-01)

Chromatin structure in cancer
per: Meng Wang, et al.
Publicat: (2022-07-01)

Robotics in Endometrial Cancer Care
per: Joseph Ng
Publicat: (2013-11-01)

The modern management of endometrial cancer
per: Catherine M. Holland, et al.
Publicat: (2011-12-01)

The modern management of endometrial cancer
per: Catherine M. Holland, et al.
Publicat: (2011-12-01)

GENETIC ASPECTS OF ENDOMETRIAL CANCER
per: V. A. Pushkarev, et al.
Publicat: (2014-09-01)

The Role of Selected Adipocytokines in Ovarian Cancer and Endometrial Cancer
per: Sebastian Stępień, et al.
Publicat: (2023-04-01)

Racioethnic Disparities in Endometrial Cancer Outcomes
per: Ojone Illah, et al.
Publicat: (2024-02-01)

TRENDS OF ENDOMETRIAL CANCER IN CENTRAL INDIA: AN INSTITUTIONAL REVIEWTrends of Endometrial Cancer in Central India: An Institutional Review
per: Dhruv G Patel, et al.
Publicat: (2020-06-01)

Management of inoperable endometrial cancer
per: Supakorn Pitakkarnkul, et al.
Publicat: (2022-07-01)

The Roles of Endoscopy in Endometrial Cancer
per: Chyi-Long Lee, et al.
Publicat: (2008-12-01)

PREDICTION ENDOMETRIAL CANCER IN WOMEN WITH ENDOMETRIAL HYPERPLASTIC PROCESSES IN PREMENOPAUSAL
per: A. L. Unanyan, et al.
Publicat: (2016-09-01)

The Exploration of Chemokines Importance in the Pathogenesis and Development of Endometrial Cancer
per: Jakub Dobroch, et al.
Publicat: (2022-03-01)

KLHL14, an ovarian and endometrial-specific gene, is over-expressed in ovarian and endometrial cancer
per: Mi Han, et al.
Publicat: (2020-01-01)

Assessment of Preoperative Endometrial Histopathological Sampling as a Predictor of Final Surgical Pathology in Endometrial Cancer
per: Mario Augusto Silveira Bueno Piotto, et al.

Telomeres and telomerase in endometrial cancer and hyperplasia
per: Anna Pańczyszyn, et al.
Publicat: (2024-03-01)

Epidemiology of Endometrial Cancer in North of Iran
per: Shahla Yazdani, et al.
Publicat: (2017-01-01)

The significance of markers in the diagnosis of endometrial cancer
per: Monika M. Żyła, et al.
Publicat: (2016-11-01)

Role of transcription factors and chromatin modifiers in driving lineage reprogramming in treatment-induced neuroendocrine prostate cancer
per: Amritha Sreekumar, et al.
Publicat: (2023-01-01)

Preoperative Haematologic Markers for the Differentiation of Endometrial Cancer from Benign Endometrial Lesions in Postmenopausal Patients with Endometrial Masses
per: Song YJ, et al.
Publicat: (2023-10-01)

Accuracy of Pre-operative Endometrial Sampling for the Detection of High Grade Endometrial Cancer
per: Uraiwan Khomphaiboonkij, et al.
Publicat: (2015-09-01)

Telomerase and Telomeres in Endometrial Cancer
per: Rafah A. A. Alnafakh, et al.
Publicat: (2019-05-01)

Comparison of Oncological and Surgical Outcomes of Robot-Assisted, Laparoscopic Modified Radical Hysterectomy and Laparotomy for Endometrial Cancer
per: Masako Ishikawa, et al.
Publicat: (2024-02-01)

Chromatin and the DNA damage response: The cancer connection
per: Martijn S. Luijsterburg, et al.
Publicat: (2011-08-01)

Psychometric validation of the Functional Assessment of Cancer Therapy‐Endometrial among endometrial cancer patients
per: Sooyeon Kim, et al.
Publicat: (2024-03-01)

Model Predicting the Risk of Endometrial Hyperplasia Developing into Endometrial Cancer
per: Su J, et al.
Publicat: (2024-09-01)

SENTINEL LYMPH NODES IN ENDOMETRIAL CANCER
per: A. I. Berishvili, et al.
Publicat: (2017-06-01)

Breast cancer in the setting of fertility-sparing treatment for endometrial cancer
per: Haley A. Moss, et al.
Publicat: (2014-12-01)

Axin2+ endometrial stem cells: the source of endometrial regeneration and cancer
per: Shafiq M. Syed, et al.
Publicat: (2020-05-01)

Rapid identification of endometrial hyperplasia and endometrial endometrioid cancer in young women
per: Dan Kuai, et al.
Publicat: (2023-07-01)

A multiomics comparison between endometrial cancer and serous ovarian cancer
per: Hui Zhong, et al.
Publicat: (2020-01-01)